Company Spotlight

Arthur G. Russell Co. Inc., The

750 Clark Avenue
Bristol, CT 06010
United States
View Profile


Outsourcing Directory


IntriCon





Company Headquarters

1260 Red Fox Road
Arden Hills, MN 55112
United States

Company Description

IntriCon’s mission is to enhance the mobility and effectiveness of body-worn devices that connect people to people and to the devices around them.

Outsourcing Directory

    Related Content

    • CSA Medical Receives European Approval for its RejuvenAir System

      CSA Medical Receives European Approval for its RejuvenAir System

      New technology treats COPD patients with chronic bronchitis.
      PRNewswire 12.02.19

    • Surgical
      J&J to Pay $117M to Settle Pelvic Mesh Lawsuits

      J&J to Pay $117M to Settle Pelvic Mesh Lawsuits

      Consumers were misled about safety, effectiveness, and potential risks of transvaginal mesh devices.
      New York State Attorney General 10.18.19

    • Patient Monitoring
      Patient Monitoring Device Market to Exceed $27B by 2025

      Patient Monitoring Device Market to Exceed $27B by 2025

      The rising prevalence of chronic health conditions will fuel patient monitoring devices' market size.
      Global Market Insights 10.15.19


    • Cardiovascular | Diagnostics
      FlowMet-R Gets FDA 510K Clearance

      FlowMet-R Gets FDA 510K Clearance

      Non-invasive blood flow monitoring device.
      PRNewswire 10.02.19

    • Cardiovascular
      Medtronic Announces Early Feasibility Trial for Intrepid

      Medtronic Announces Early Feasibility Trial for Intrepid

      Study shows momentum in establishing a less invasive approach to treat patients with mitral valve disease.
      Medtronic 10.01.19

    • Attorney General Morrisey Sues Johnson & Johnson

      Attorney General Morrisey Sues Johnson & Johnson

      Alleges that the company engaged in unlawful and deceptive marketing practices.
      West Virginia Attorney General's Office 09.19.19


    • OS-SiA, a Next-Gen AI-Enabled Digital Scanner, is Launched by OptraSCAN

      OS-SiA, a Next-Gen AI-Enabled Digital Scanner, is Launched by OptraSCAN

      Smart scanner is designed to scan and analyze tissue at the same time.
      Business Wire 09.11.19

    • ivWatch Positioned for Market Entry with Australian and European Patent Grants

      ivWatch Positioned for Market Entry with Australian and European Patent Grants

      ivWatch now has 17 global patents protecting its technologies.
      Business Wire 08.14.19

    • The Bionic Glove

      The Bionic Glove

      A stroke, an accident — and suddenly your hand no longer works as it should. A novel product by two medical technicians promises help.


    • Motus GI Adds Two Key Senior Managers to its Executive Team

      Motus GI Adds Two Key Senior Managers to its Executive Team

      Management team to drive commercial launch of Pure-Vu GEN2 in the U.S. hospital market.
      Business Wire 08.06.19

    • Cardiovascular
      ROADSTER-2 Demonstrates Compelling Patient Outcomes With Strong Safety Profile

      ROADSTER-2 Demonstrates Compelling Patient Outcomes With Strong Safety Profile

      The results continue to show the safety, effectiveness and clinical advantages of TCAR, as well as its short learning curve.
      Silk Road Medical Inc. 08.02.19

    • Hemovent Receives CE Marking for MOBYBOX ECLS System

      Hemovent Receives CE Marking for MOBYBOX ECLS System

      MOBYBOX is a miniaturized heart/lung machine that uses Hemovent’s proprietary Bionique Flow Technologies as its platform.
      Business Wire 07.10.19


    • Contract Manufacturing | Electronics | Neurological
      Designing Neurostimulator Devices with Manufacturability in Mind

      Designing Neurostimulator Devices with Manufacturability in Mind

      Designers and manufacturers of neurostimulators should consider revamping the lead interface to best incorporate new external pulse generators.
      Matt Hedlund, Senior Applications Engineer, Benchmark 06.25.19

    • Motus GI Receives FDA Clearance to Market Pure-Vu GEN2

      Motus GI Receives FDA Clearance to Market Pure-Vu GEN2

      Clearance marks key regulatory milestone and advances commercial strategy for launch in U.S. hospital market in 2019.
      Business Wire 06.11.19